Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INCEPTUS: A Prospective, Non-Interventional Clinical Assessment Study in X Linked Myotubular Myopathy (XLMTM) Subjects Aged 3 Years and Younger

NCT02704273 is registered in ClinicalTrials.gov with Astellas Gene Therapies as lead sponsor.

NCT NCT02704273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02704273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INCEPTUS: A Prospective, Non-Interventional Clinical Assessment Study in X Linked Myotubular Myopathy (XLMTM) Subjects Aged 3 Years and Younger
Lead sponsor
Astellas Gene Therapies
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
September 30, 2019
Enrollment
34 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked myotubular myopathy